Company Name, Ticker, Competitors, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
BBLG's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Bone Biologics Corporation News
Bone Biologics Corporation's Revenue Growth
Bone Biologics Corporation's Executive Officers
Bone Biologics Corporation Business Description
Bone Biologics Corporation Executive Officers
Economic Indicators
Fundamentals
Bone Biologics Corporation Growth Rates
Bone Biologics Corporation Profitability
Bone Biologics Corporation Valuation
Bone Biologics Corporation Management Effectiveness
Bone Biologics Corporation Financial Strength
Bone Biologics Corporation Efficiency
Bone Biologics Corporation Dividend
Financials
Bone Biologics Corporation Business Segments
Bone Biologics Corporation Income Statement
Bone Biologics Corporation Balance Sheets
Bone Biologics Corporation Cash Flow Statement
Bone Biologics Corporation Geographic Information
Suppliers
Bone Biologics Corporation Suppliers Performance
BBLG Suppliers Stock Performance
BBLG Suppliers Growth Rates
BBLG Suppliers Data
BBLG Suppliers Efficiency
BBLG Suppliers Management Effectiveness
BBLG Suppliers Valuation
BBLG Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Bone Biologics Corporation Market Share
Bone Biologics Corporation Competition Performance
Bone Biologics Corporation Competitors Results
BBLG Competitors Stock Performance
BBLG Competitors Growth Rates
BBLG Workforce Efficiency at the Competitors
BBLG Competitors Efficiency
BBLG Competitors Management Effectiveness
BBLG Competitors Valuation
Customers & Markets
Bone Biologics Corporation Customers Demand
BBLG Customers Expenditure Growth Rates
BBLG Customers Performance
BBLG Customers Stock Performance
BBLG Customers Growth Rates
BBLG Workforce Efficiency at the Customers
BBLG Customers Efficiency
BBLG Customers Management Effectiveness
BBLG Customers Valuation
BBLG Customers by Companys' Segments
Charts & Quotes
Bone Biologics Corporation Comparison Charts
BBLG OHLC Charts
BBLG's Tehnical Upper Indicators
BBLG's Tehnical Lower Indicators
BBLG's Weekly Charts
BBLG's Monthly Charts
Bone Biologics Corporation's Profile
Company Charts and Quotes
Bone Biologics Corporation News
Bone Biologics Corporation's Business Description
Bone Biologics Corporation's Income Statement
Bone Biologics Corporation's Balance Sheets
Bone Biologics Corporation's Cash Flow Statement
Bone Biologics Corporation's Profitability
Bone Biologics Corporation's Financials
BBLG's Long Term Debt to Equity
Bone Biologics Corporation's Suppliers
Bone Biologics Corporation's Competitors
Bone Biologics Corporation's Markets & Customers
Bone Biologics Corporation's Market Share
BBLG's Suppliers Performance
BBLG's Competitors Stock Performance
BBLG's Charts MACD
Bone Biologics Corporation's Customers Expenditure Growth Rates
Economic Indicators
Revenue per Employee by Industry
Efficiency Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Housing Starts
News
Economy News
Stock News
Hotel & Leisure Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Cash Flow Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Bone Biologics Corporation
(
BBLG
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Medical Equipment & Supplies
Industry
•
Medical Equipment & Supplies
Sector
•
Healthcare
Bone Biologics's Yearly Net Cash Flow Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Net Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Net Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
BBLG Annual Net Cash Flow Growth
2023
2022
2021
2020
2019
Y / Y Annual Net Cash Flow Change
-
-87.07 %
-
-
-
Annual Net Cash Flow (in millions $)
$-4.51
$0.86
$6.68
$-0.02
$-0.93
BBLG Company Profile
>>
Back to BBLG Fundamentals at a Glance
>>
Back to BBLG Growth Comparisons
Annual Net Cash Flow Growth Comment
Bone Biologics Corporation
realized net cash outflow compare to Annual Net Cash Flow a year ago.
Bone Biologics Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2023 Annual Net Cash Flow within Healthcare Sector
Y/Y Net Cash Flow Growth %
2023 Annual Net Cash Flow
Biomarin Pharmaceutical Inc
-77.71 %
$ 30.596 millions
P3 Health Partners Inc
-83.41 %
$ 22.477 millions
West Pharmaceutical Services Inc